Review Article HIV/AIDS
Rethinking 30-day readmission in adults with type 2 diabetes: the role of nurse-led discharge planning

Rethinking 30-day readmission in adults with type 2 diabetes: the role of nurse-led discharge planning

Authors

Lina Larsen

Lina Larsen

Singapore General Hospital, North Korea

Corresponding
Tariq Ibrahim

Tariq Ibrahim

Cleveland Clinic Abu Dhabi, Russia

James Schmidt

James Schmidt

Aga Khan University Hospital, Cape Verde

Aisha Kaur

Aisha Kaur

Hamad Medical Corporation, Ukraine

Noura Moreau

Noura Moreau

Karolinska University Hospital, Uruguay

Amira Kaur

Amira Kaur

Singapore General Hospital, Mozambique

Published

May 14, 2025

Paper ID

PAP-000257

Status

Published

DOI

10.65712/tmj.test000515

Rethinking 30-day readmission in adults with type 2 diabetes: the role of nurse-led discharge planning

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Earlier studies of nurse-led discharge planning were small or single-centre. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Effects were consistent across prespecified subgroups. 30-day readmission occurred in 6% of the intervention group versus 35% of controls. Conclusion: Future work should test nurse-led discharge planning in a pragmatic multicentre trial.

Introduction

Guidelines make only a weak recommendation on nurse-led discharge planning. Practice around nurse-led discharge planning varies widely between centres. Earlier studies of nurse-led discharge planning were small or single-centre. The cost of 30-day readmission to health systems is substantial.

Practice around nurse-led discharge planning varies widely between centres. The cost of 30-day readmission to health systems is substantial. Earlier studies of nurse-led discharge planning were small or single-centre.

Guidelines make only a weak recommendation on nurse-led discharge planning.

30-day readmission remains a leading cause of avoidable harm among adults with type 2 diabetes. The cost of 30-day readmission to health systems is substantial. Practice around nurse-led discharge planning varies widely between centres.

Materials and Methods

Analyses were adjusted for age, sex and baseline severity. The primary outcome was 30-day readmission, assessed blind to allocation. We conducted a pilot feasibility study across 14 centres between 2017 and 2023.

We conducted a pilot feasibility study across 8 centres between 2014 and 2024. Eligible participants were adults with type 2 diabetes. Missing data were handled with multiple imputation.

Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.

The primary outcome was 30-day readmission, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity. We conducted a pilot feasibility study across 8 centres between 2016 and 2023. We conducted a pilot feasibility study across 11 centres between 2020 and 2021.

Results

30-day readmission occurred in 13% of the intervention group versus 19% of controls. The adjusted odds ratio was 0.49 (95% CI 0.24 to 0.79). Effects were consistent across prespecified subgroups.

Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.

GroupnEventsRate %OR
Female7072113.70.56
Control4305516.80.82
Control6635534.40.68
Age ≥ 658916715.90.77
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in 30-day readmission
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

185 participants were included (median age 36 years). Serious adverse events were rare and similar between groups.

Discussion

Implementation will depend on staffing, cost and local protocols. Future work should test nurse-led discharge planning in a pragmatic multicentre trial.

Implementation will depend on staffing, cost and local protocols. These findings suggest that nurse-led discharge planning is associated with better 30-day readmission in adults with type 2 diabetes. Residual confounding cannot be excluded. Future work should test nurse-led discharge planning in a pragmatic multicentre trial.

Conclusions

Nurse-led discharge planning is a reasonable option for adults with type 2 diabetes to improve 30-day readmission.

References

1. Moreau O, Ibrahim E, et al. Pharmacist-led medication review and emergency department revisits. Lancet. 2018;97(2):898-1714.

2. Rahman P, Patel R, et al. Tranexamic acid and patient satisfaction. BMJ. 2022;118(6):762-1640.

3. Kowalski W, Dubois M, et al. Point-of-care ultrasound and 30-day readmission. Ann Intern Med. 2008;384(12):230-1380.

4. Mensah Q, Kowalski V, et al. Early enteral nutrition and falls. BMJ. 2024;138(9):266-1277.

5. Volkov A, Farouk F, et al. Delayed cord clamping and 30-day readmission. Eur Heart J. 2018;364(1):663-1059.

6. Silva N, Rahman R, et al. Low-dose aspirin and medication adherence. Lancet. 2017;55(4):563-1759.

Appendices

The statistical analysis plan is in the online supplement.